Eberhard Karls Universität Tübingen

University / College


Location: Tübingen, Germany (DE) DE

ISNI: 0000000121901447

ROR: https://ror.org/03a1kwz48

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network (2017) Fremd C, Hack C, Schneeweiss A, Rauch G, Wallwiener D, Brucker SY, Taran FA, et al. Journal article Update Breast Cancer 2017 - Implementation of Novel Therapies (2017) Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, et al. Journal article H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study (2017) Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Rueff F, Jakob T, et al. Journal article ADF Winter School-An exciting concept of the Arbeitsgemeinschaft Dermatologische Forschung to connect young scientists and clinician scientists in Dermatology at the top of Germany (2017) Yazdi AS, Barlin M, Boehm K, Gendrisch F, Ghorbanalipoor S, Haeberle S, Hamel A, et al. Journal article, other Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014) (2017) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article Fear of progression in patients with low-risk malignant melanoma (2017) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Conference contribution ELEVATED MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) PREDICTS RELAPSES IN RA PATIENTS IN SUSTAINED REMISSION TAPERING TUMOUR NECROSIS FACTOR INHIBITOR THERAPY-RESULTS FROM THE RANDOMIZED CONTROLLED RETRO STUDY (2017) Rech J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, et al. Conference contribution MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION (2017) Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, et al. Conference contribution Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat (2017) Amato D, Canneva F, Huu Phuc Nguyen , Bauer P, Riess O, von Hörsten S, Müller CP Journal article A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus (2017) Zenner HP, Delb W, Kroener-Herwig B, Jaeger B, Peroz I, Hesse G, Mazurek B, et al. Journal article